Axios @axios
The FDA is delaying a decision on approving Moderna's coronavirus vaccine for adolescents ages 12-17 to evaluate the risk of myocarditis after vaccination, Moderna says. https://t.co/7qoHapuPfQ — PolitiTweet.org
Created
Sun Oct 31 18:09:37 +0000 2021
Likes
34
Retweets
20
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
The FDA is delaying a decision on approving Moderna's coronavirus vaccine for adolescents ages 12-17 to evaluate the risk of myocarditis after vaccination, Moderna says. https://t.co/7qoHapuPfQ — PolitiTweet.org